Zobrazeno 1 - 10
of 1 607
pro vyhledávání: '"Tavakolpour, S."'
Autor:
Tavakolpour S; Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran., Noormohammadi Z; Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran., Daneshpazhooh M; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Gholami A; Virology Department, Pasteur Institute of Iran, Tehran, Iran., Mahmoudi H; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Oct 02; Vol. 15, pp. 1469937. Date of Electronic Publication: 2024 Oct 02 (Print Publication: 2024).
Autor:
Habibi MA; Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Ahmadpour S; Patient Safety Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran., Tafaroji J; Pediatric Medicine Research Center, Qom University of Medical Sciences, Qom, Iran., Eazi SM; Student Research Committee, Qom University of Medical Sciences, Qom, Iran., Mineaie P; Student Research Committee, Qom University of Medical Sciences, Qom, Iran., Mohammadpour Y; Patient Safety Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran., Tavakolpour S; Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Publikováno v:
Current drug targets [Curr Drug Targets] 2024 Sep 23. Date of Electronic Publication: 2024 Sep 23.
Autor:
Mohammad Piri S; Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: muhammadpiri25@gmail.com., Amin Habibi M; Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: mohammad.habibi1392@yahoo.com., Shool S; Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: shoolsina@gmail.com., Khazaeli Najafabadi M; Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: m.khazaeli68@gmail.com., Ahmadpour S; Patient Safety Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran. Electronic address: sajjadahmadpour@yahoo.com., Alemi F; School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. Electronic address: f.alemi933@gmail.com., Aria Nejadghaderi S; Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran. Electronic address: ariang20@gmail.com., Shokri P; Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: shokri.pourya@yahoo.com., Abdi M; Student Research Committe, Faculty of Medicine, North Khorasan University of Medical Sciences, Bonjnurd, Iran. Electronic address: mhtrmbdy@gmail.com., Asghari N; Student Research Committe, Faculty of Medicine, North Khorasan University of Medical Sciences, Bonjnurd, Iran. Electronic address: asghari.negin77@gmail.com., Amir Asef-Agah S; Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: aseyedamir@gmail.com., Tavakolpour S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: soheil_tavakolpour@dfci.harvard.edu.
Publikováno v:
Human immunology [Hum Immunol] 2024 Sep; Vol. 85 (5), pp. 110838. Date of Electronic Publication: 2024 Jul 05.
Autor:
Lorestani P; Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran., Dashti M; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Nejati N; Pediatric Cell and Gene Therapy Research Centre, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Habibi MA; Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran., Askari M; Department of Nanobiotechnology, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran., Robat-Jazi B; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran., Ahmadpour S; Patient Safety Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran. sajjadahmadpour@yahoo.com., Tavakolpour S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA. soheil_tavakolpour@dfci.harvard.edu.
Publikováno v:
Discover oncology [Discov Oncol] 2024 Aug 26; Vol. 15 (1), pp. 369. Date of Electronic Publication: 2024 Aug 26.
Autor:
Rakhshandehroo T; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Mantri SR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Moravej H; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Louis BBV; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Salehi Farid A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Munaretto L; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Regan K; Department of Biomedical Engineering, Boston University, Boston, MA, USA., Khan RMM; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Wolff A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Farkash Z; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Cong M; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Kuhnast A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Nili A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Lee UJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Allen HH; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Berland L; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Simkova E; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Uslu SC; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Tavakolpour S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Rowley JE; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biomedical Engineering, Boston University, Boston, MA, USA., Codet E; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Shahbazian H; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Baral J; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Pyrdol J; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Jacobson CA; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Nadeem O; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Nia HT; Department of Biomedical Engineering, Boston University, Boston, MA, USA., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA., Rashidian M; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA. Mohammad_rashidian@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Mohammad_rashidian@dfci.harvard.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. Mohammad_rashidian@dfci.harvard.edu.; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Mohammad_rashidian@dfci.harvard.edu.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2024 Jul 30. Date of Electronic Publication: 2024 Jul 30.
Autor:
Kianfar N; Drs. Kianfar, Dasdar, Marashi, Mahmoudi, and Daneshpazhooh are with the Autoimmune Bullous Diseases Research Center at Tehran University of Medical Sciences in Tehran, Iran., Dasdar S; Drs. Kianfar, Dasdar, Marashi, Mahmoudi, and Daneshpazhooh are with the Autoimmune Bullous Diseases Research Center at Tehran University of Medical Sciences in Tehran, Iran., Marashi A; Drs. Kianfar, Dasdar, Marashi, Mahmoudi, and Daneshpazhooh are with the Autoimmune Bullous Diseases Research Center at Tehran University of Medical Sciences in Tehran, Iran., Tavakolpour S; Dr. Tavakolpour is with the Dana-Farber Cancer Institute, Harvard Medical School in Boston, Massachusetts., Mahmoudi H; Drs. Kianfar, Dasdar, Marashi, Mahmoudi, and Daneshpazhooh are with the Autoimmune Bullous Diseases Research Center at Tehran University of Medical Sciences in Tehran, Iran., Daneshpazhooh M; Drs. Kianfar, Dasdar, Marashi, Mahmoudi, and Daneshpazhooh are with the Autoimmune Bullous Diseases Research Center at Tehran University of Medical Sciences in Tehran, Iran.
Publikováno v:
The Journal of clinical and aesthetic dermatology [J Clin Aesthet Dermatol] 2024 Jul; Vol. 17 (7), pp. 24-36.
Autor:
Nili A; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Karimi S; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Salehi Farid A; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Molhem Azar P; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Farimani Z; Department of Periodontics, School of Dentistry, Alborz University of Medical Science, Karaj, Iran., Shahbazian H; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Balighi K; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Tavakolpour S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Mahmoudi H; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Daneshpazhooh M; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Publikováno v:
Oral diseases [Oral Dis] 2023 Jul; Vol. 29 (5), pp. 2248-2255. Date of Electronic Publication: 2022 Jun 09.
Autor:
Daneshvar E; Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Tavakolpour S; Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Mahmoudi H; Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Daneshpazhooh M; Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Teimourpour A; Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Aslani S; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran., Balighi K; Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.; Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Publikováno v:
International journal of dermatology [Int J Dermatol] 2023 Apr; Vol. 62 (4), pp. 567-574. Date of Electronic Publication: 2022 Jul 27.
Autor:
Uslu SC; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States.; Medical Scientist Training Program, Hacettepe University Faculty of Medicine, Ankara 06230, Turkey., Lee UJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States., Tavakolpour S; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States., Abousaway O; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States., Nili A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States., Bass L; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States., Purwar P; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States., Lacson E; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States., Berland L; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States.; CNRS, INSERM, IRCAN, Université Côte d'Azur, 06100 Nice, France., Kuhnast A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States., Clark LM; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States., Picard D; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States., Rakhshandehroo T; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States., Mantri SR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States., Moravej H; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States., Rashidian M; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States.; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, United States.; Parker Institute for Cancer Immunotherapy, San Francisco, California 94129, United States.
Publikováno v:
ACS pharmacology & translational science [ACS Pharmacol Transl Sci] 2024 May 24; Vol. 7 (6), pp. 1746-1757. Date of Electronic Publication: 2024 May 24 (Print Publication: 2024).
Autor:
Aryanian Z; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Department of Dermatology, Babol University of Medical Sciences, Babol, Iran., Tahooneban A; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran., Balighi K; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Department of Dermatology, School of Medicine Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Daneshpazhooh M; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Department of Dermatology, School of Medicine Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Mahmoudi H; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Department of Dermatology, School of Medicine Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran., Soori T; Department of Infectious Diseases, Tehran University of Medical Sciences, Tehran, Iran., Mohseniafshar Z; Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran., Tavakolpour S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Hatami P; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Publikováno v:
Dermatologic therapy [Dermatol Ther] 2022 Nov; Vol. 35 (11), pp. e15783. Date of Electronic Publication: 2022 Sep 04.